Abstract
Prostaglandin E2 plays multiple roles both in the physiology and the physiopathology of human brain, which are not completely understood. We have identified in a subset of human glioblastoma multiforme (GBM) tumors, the most common form of adult brain cancer, an increased expression of mPGES-1, the enzyme which catalyses the isomerization of PGH2 into PGE2 downstream of cyclooxygenase 2 (COX-2). The sensitivity of primary cultures of GBM to apoptosis was augmented by the overexpression of mPGES-1, whereas the knockdown of its expression by shRNA decreased the apoptotic threshold in vitro and stimulated tumor growth in vivo. Adding extracellular PGE2 in the culture medium failed to reproduce mPGES-1 effect on the cell viability in vitro. However, the intracellular injection of PGE2 induced a dose-dependent apoptosis in GBM cultures, which was dependent on the presence of Bax, a pro-apoptotic protein. We show that PGE2 physically associates with Bax, triggering its apoptotic-like change in conformation and its subsequent association with mitochondria. Our results raise questions about the role of PGE2 in the control of apoptosis and in its potential impact in central nervous system pathologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- COX-2:
-
cyclooxygenase 2
- mPGES-1:
-
microsomal prostaglandin E2 synthase
- GBM:
-
Glioblastoma multiforme
- BeGBM:
-
Bax-expressing GBM
- BdGBM:
-
Bax-deficient GBM
- PGE2:
-
prostaglandin E2
- PGD2:
-
prostaglandin D2
- IVT:
-
in vitro translated
- AchE:
-
acetylcholine esterase
References
Berry CN, Hoult JRS, Peers SH, Agback H . (1983). Inhibition of prostaglandin 15-hydroxydehydrogenase by sulphasalazine and a novel series of potent analogues. Biochem Pharmacol 32: 2863–2871.
Breyer RM, Bagdassarian CK, Myers SA, Breyer MD . (2001). Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661–690.
Brown DM, Phipps RP . (1996). Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. J Immunol 157: 1359–1370.
Buccoliero AM, Caldarella A, Gheri CF, Taddei A, Paglierani M, Pepi M et al. (2006). Inducible cyclooxygenase (COX-2) in glioblastoma - clinical and immunohistochemical (COX-2-VEGF) correlations. Clin Neuropathol 25: 59–66.
Cartron P-F, Priault M, Oliver L, Meflah K, Manon S, Vallette FM . (2003a). The N-terminal end of Bax contains a mitochondrial-targeting signal. J Biol Chem 278: 11633–11641.
Cartron PF, Gallenne T, Bougras G, Gautier F, Manero F, Vusio P et al. (2004a). The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol Cell 16: 807–818.
Cartron PF, Juin P, Oliver L, Martin S, Meflah K, Vallette FM . (2003b). Nonredundant role of Bax and Bak in Bid-mediated apoptosis. Mol Cell Biol 23: 4701–4712.
Cartron PF, Oliver L, Mayat E, Meflah K, Vallette FM . (2004b). Impact of pH on Bax alpha conformation, oligomerisation and mitochondrial integration. FEBS Lett 578: 41–46.
Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS . (2005). Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310: 1504–1510.
Cha YI, Solnica-Krezel L, DuBois RN . (2006). Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Devl Biol 289: 263–272.
Chen C, Bazan NG . (2005). Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 93: 929–941.
Cory S, Adams JM . (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647–656.
Gasparini G, Longo R, Sarmiento R, Morabito A . (2003). Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4: 605–615.
Gupta RA, Dubois RN . (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11–21.
Hara A, Okayasu I . (2004). Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathologica 108: 43–48.
Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J et al. (2005). IKK mediates ischemia-induced neuronal death. Nat Med 11: 1322–1329.
Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K . (2004). Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol 66: 1643–1651.
Hsu YT, Wolter KG, Youle RJ . (1997). Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 94: 3668–3672.
Hsu YT, Youle RJ . (1997). Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272: 13829–13834.
Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S et al. (2004). JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 101: 665–670.
Jakobsson PJ, Morgenstern R, Mancini J, Ford-Hutchinson A, Persson B . (1999a). Common structural features of MAPEG – a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci 8: 689–692.
Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B . (1999b). Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220–7225.
Juin P, Pelletier M, Oliver L, Tremblais K, Gregoire M, Meflah K et al. (1998). Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 273: 17559–17564.
Kawai N, Tsujii M, Tsuji S . (2002). Cyclooxygenases iand colon cancer. Prostaglandins Lipid Mediat 68-69: 187–196.
Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA . (2006). Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12: 225–229.
Krunic N, Adamson SL, Ackerley C, Okita RT, Coceani F . (2000). Perinatal changes in choroidal 15-hydroxyprostaglandin dehydrogenase: implications for prostaglandin removal from brain. Brain Res Dev Brain Res 121: 145–155.
Kudo I, Murakami M . (2005). Prostaglandin e synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 38: 633–638.
Manabe Y, Anrather J, Kawano T, Niwa K, Zhou P, Ross ME et al. (2004). Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann Neurol 55: 668–675.
McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q et al. (2004). Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24: 257–268.
Musiek ES MG, McLaughlin B, Morrow JD . (2005). Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol 15: 149–158.
Park JY, Pillinger MH, Abramson SB . (2006). Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119: 229–240.
Patsos HA, Hicks DJ, Dobson RRH, Greenhough A, Woodman N, Lane JD et al. (2005). The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 54: 1741–1750.
Perez-Sala D, Cernuda-Morollon E, Canada FJ . (2003). Molecular basis for the inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. J Biol Chem 278: 51251–51260.
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . (1997). A model for p53-induced apoptosis. Nature 389: 300–305.
Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. PNAS 100: 9244–9249.
Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S . (2003). Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5: 320–329.
Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF . (2001). Cyclooxygenase-2 expression in human gliomas: pronostic significance and molecular correlations. Cancer Res 61: 4375–4381.
Takadera T, Yumoto H, Tozuka Y, Ohyashiki T . (2002). Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317: 61–64.
Teismann P, Tieu K, Choi D-K, Wu D-C, Naini A, Hunot S et al. (2003). Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. PNAS 100: 5473–5478.
Tessner TG, Muhale F, Riehl TE, Anant S, Stenson WF . (2004). Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and Bax translocation. J Clin Invest 114: 1676–1685.
Wang D, DuBois RN . (2006). Prostaglandins and cancer. Gut 55: 115–122.
Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN . (2000). Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105: 1589–1594.
Yucel-Lindberg T, Olsson T, Kawakami T . (2006). Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts. Cell Signal 18: 2131–2142.
Acknowledgements
This work was supported by a special grant from the Ligue contre le Cancer (Equipe labellisée Ligue). We thank Professor PJ Jakobsson (Karolinska Institutet, Sweden) for the gift of mPGES-1 cDNA and antibody, Dr J Grassi (CEA/Saclay, France) for the gift of AChE-coupled PGE2 and recombinant AChE, Drs P Juin and L Oliver (INSERM U601) for fruitful advices and comments. We thank also Professor JF Mosnier (Department of Anatomo-Pathology, CHU G&R Laennec, Nantes) for his support throughout this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Lalier, L., Cartron, PF., Pedelaborde, F. et al. Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients’ survival in glioblastoma multiforme. Oncogene 26, 4999–5009 (2007). https://doi.org/10.1038/sj.onc.1210303
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210303
Keywords
This article is cited by
-
DAXX-ATRX regulation of p53 chromatin binding and DNA damage response
Nature Communications (2022)
-
Intracellular prostaglandin E2 contributes to hypoxia-induced proximal tubular cell death
Scientific Reports (2021)
-
TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosis
Cell Death & Disease (2021)
-
Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells
Cellular and Molecular Life Sciences (2015)
-
Bioactive lipids and the control of Bax pro-apoptotic activity
Cell Death & Disease (2014)